ajanta pharma share short term technical view
Ajanta pharma share price today trading at 1400 rupee level with 2% loss. On daily chart, stock price trend is still up but momentum is weak as continues profit booking is seen in stock. Stock is trading below 1 month average and heading towards 3 month average support. 1340 is final short term support of 3 month average while 1450 is strong resistance of 1 month average level. For short term expect weakness in stock price and expect downside targets of 1340 and below. Above 1460 trend reversal happen and in that case stock might show 1700 plus levels with short to medium term period.
ajanta pharma share medium term technical view
Ajanta pharma share on weekly chart showing losses for the week. This will be 3rd losing week for this stock. In these 3 weeks period stock tumbled from 1665 to 1400 levels. On weekly chart, 1370 and 1260 are major average supports while 1650 will remain top resistance. Weekly chart price as well as indicators patterns are bearish. From medium term, stock is in Bull Run and if sustain above 1300 level expect trend to continue for fresh high.
ajanta pharma share long term technical view
Ajanta share in last 6 month had given 42% return to investors and outperforming the market. Fundamentally stock looks good and around 1000 rupee will be best entry point if deep correction happen. As per my chart, without stock split/dividend adjustment, Ajanta pharma share all time low was 13 rupee made in 2003. While Ajanta pharma share all time high was at 1665 made in 2015. For next 3 to 5 years view, stock has potential to show levels above 2000 so long term investors can follow buy and accumulate view on every major correction phase.
Ajanta pharma company description
Ajanta Pharma Limited is a pharmaceutical company engaged in development, research, manufacture and marketing of dosages in domestic and international markets. Ajanta operates with five manufacturing facilities, four in India and one in Mauritius that produce pharmaceutical products. It is engaged in commercializing generic products and combination products in the therapeutic areas of anti-malarial, cardiovascular, dermatology, male erectile dysfunction, musculoskeletal and ophthalmology. Its manufacturing capabilities include a range of dosage forms of allopathic drugs, including tablets, capsules, ointments, injections and dry powder. Its key products include the brand called Kamagra, for the treatment of Male Erectile Dysfunction (MED) and Artefan, for the treatment of malaria. The Companies subsidiaries include Ajanta Pharma (Mauritius) Limited, Ajanta Pharma USA Inc., and Ajanta Pharma Philippines Inc.